Grants per year
Fingerprint
Dive into the research topics where Krishnan Warrior is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants
- 1 Active
-
Prot #1490-0004: A Phase IIa/IIb, Randomised, Double Blind, Placebo-Controlled, Parallel-Group DoseFinding Study to Examine the Efficacy and Safety of BI 1839100 Administered Orally Over a 12-Week Treatment Period in Patients with Idiopathic Pulmonary Fib
Warrior, K. (PD/PI)
Boehringer Ingelheim Pharmaceuticals, Inc.
12/16/24 → 12/16/27
Project: Research project
-
Impact of Acute Exacerbation of Idiopathic Pulmonary Fibrosis on Lung Transplant Outcomes
Warrior, K., Sayad, K., O'Hara, C. P. & Dilling, D. F., Jun 1 2024, In: Transplantation. 108, 6, p. 1460-1465 6 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Practice Patterns for Screening and Treating Interstitial Lung Disease-related Pulmonary Hypertension at Specialty Care Centers in the United States
Khan, S. L., Danoff, S. K., Kulkarni, T., Reichuber, J., Shifren, A., Shlobin, O. A., Thavarajah, K., Warrior, K. & Case, A. H., Jul 2024, In: Annals of the American Thoracic Society. 21, 7, p. 1103-1106 4 p.Research output: Contribution to journal › Letter › peer-review
-
Lung transplantation for lymphangioleiomyomatosis
Warrior, K. & Dilling, D. F., Jan 2023, In: Journal of Heart and Lung Transplantation. 42, 1, p. 40-52 13 p.Research output: Contribution to journal › Review article › peer-review
6 Scopus citations -
A survey of use of mTOR inhibitors in patients with lymphangioleiomyomatosis listed for lung transplant
Warrior, K., Leard, L. E., Nair, A. R., Gries, C. J., Fisher, A. J., Johnson, S. R., McCormack, F. X. & Dilling, D. F., Apr 1 2022, In: Respiratory Medicine. 195, 106779.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
Use of nintedanib and pirfenidone in Non-idiopathic pulmonary fibrosis lung disease
Warrior, K., Chung, P. A., Reid, M. & Bemiss, B. C., Jul 1 2021, In: American journal of respiratory and critical care medicine. 204, 1, p. 92-94 3 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations